Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Obstructive Lung Diseases

  Free Subscription


Articles published in Lancet

Retrieve available abstracts of 21 articles:
HTML format
Text format



Single Articles


    July 2017
  1. GIBSON PG, Yang IA, Upham JW, Reynolds PN, et al
    Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (AMAZES): a randomised, double-blind, placebo-controlled trial.
    Lancet. 2017 Jul 4. pii: S0140-6736(17)31281.
    PubMed     Text format     Abstract available


  2. BRUSSELLE G, Pavord I
    Azithromycin in uncontrolled asthma.
    Lancet. 2017 Jul 4. pii: S0140-6736(17)31547.
    PubMed     Text format    


    March 2017
  3. FITZGERALD JM, Emery P
    Modifying the trajectory of asthma-are there lessons from the use of biologics in rheumatology?
    Lancet. 2017;389:1082-1084.
    PubMed     Text format    


    January 2017
  4. THE LANCET
    Clinical guidance for bronchiolitis.
    Lancet. 2017;389:128.
    PubMed     Text format    


  5. FLORIN TA, Plint AC, Zorc JJ
    Viral bronchiolitis.
    Lancet. 2017;389:211-224.
    PubMed     Text format     Abstract available


    December 2016
  6. WENZEL SE, Jayawardena S, Graham NM, Pirozzi G, et al
    Severe asthma and asthma-chronic obstructive pulmonary disease syndrome - Authors' reply.
    Lancet. 2016;388:2742.
    PubMed     Text format    


  7. XIA Y, Cao C, Li W, Shen H, et al
    Severe asthma and asthma-chronic obstructive pulmonary disease syndrome.
    Lancet. 2016;388:2741-2742.
    PubMed     Text format    


    November 2016
  8. PAPI A, Fabbri LM
    Management of patients with early mild asthma and infrequent symptoms.
    Lancet. 2016 Nov 29. pii: S0140-6736(16)32111.
    PubMed     Text format    


  9. REDDEL HK, Busse WW, Pedersen S, Tan WC, et al
    Should recommendations about starting inhaled corticosteroid treatment for mild asthma be based on symptom frequency: a post-hoc efficacy analysis of the START study.
    Lancet. 2016 Nov 29. pii: S0140-6736(16)31399.
    PubMed     Text format     Abstract available


    October 2016
  10. GUAN WJ, Zheng XY, Chung KF, Zhong NS, et al
    Impact of air pollution on the burden of chronic respiratory diseases in China: time for urgent action.
    Lancet. 2016;388:1939-1951.
    PubMed     Text format     Abstract available


    September 2016
  11. FITZGERALD JM, Bleecker ER, Nair P, Korn S, et al
    Benralizumab, an anti-interleukin-5 receptor alpha monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial.
    Lancet. 2016 Sep 5. pii: S0140-6736(16)31322.
    PubMed     Text format     Abstract available


  12. CALVERLEY PM
    COPD therapy: if two is good, is three better?
    Lancet. 2016;388:937-8.
    PubMed     Text format    


  13. THE LANCET
    Simplifying therapy for COPD.
    Lancet. 2016;388:936.
    PubMed     Text format    


  14. SINGH D, Papi A, Corradi M, Pavlisova I, et al
    Single inhaler triple therapy versus inhaled corticosteroid plus long-acting beta2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial.
    Lancet. 2016;388:963-73.
    PubMed     Text format     Abstract available


  15. CASTRO M, Bacharier LB
    Treatment for severe eosinophilic asthma-consistent effect of anti-interleukin-5 antibodies?
    Lancet. 2016 Sep 2. pii: S0140-6736(16)31537.
    PubMed     Text format    


  16. BLEECKER ER, FitzGerald JM, Chanez P, Papi A, et al
    Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting beta2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial.
    Lancet. 2016 Sep 2. pii: S0140-6736(16)31324.
    PubMed     Text format     Abstract available


    June 2016
  17. DEBAUN MR, Strunk RC
    The intersection between asthma and acute chest syndrome in children with sickle-cell anaemia.
    Lancet. 2016;387:2545-53.
    PubMed     Text format     Abstract available


  18. WATTS G
    Robert Charles Strunk.
    Lancet. 2016;387:2500.
    PubMed     Text format    


    April 2016
  19. LEVY SD, Alladina JW, Hibbert KA, Harris RS, et al
    High-flow oxygen therapy and other inhaled therapies in intensive care units.
    Lancet. 2016;387:1867-78.
    PubMed     Text format     Abstract available


  20. VESTBO J, Anderson JA, Brook RD, Calverley PM, et al
    Fluticasone furoate and vilanterol and survival in chronic obstructive pulmonary disease with heightened cardiovascular risk (SUMMIT): a double-blind randomised controlled trial.
    Lancet. 2016;387:1817-1826.
    PubMed     Text format     Abstract available


  21. BRUSSELLE G
    Vilanterol fluticasone and mortality in comorbid COPD GOLD B.
    Lancet. 2016;387:1791-2.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Obstructive Lung Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: